Author Archives: Admin

Could a molecule found in the venom of a southern African scorpion contribute to the development of new treatments for antibiotic-resistant infections?

Researchers at the University of Pretoria are investigating this possibility through Opis16a, a synthetic antimicrobial peptide derived from a molecule originally identified in the venom of Opistophthalmus carinatus, a scorpion native to southern Africa.From scorpion venom to antimicrobial researchOpis16a is a shortened version of a naturally occurring peptide called opistoporin 1. Researchers investigated its potential against drug-resistant bacteria, particularly Gram-negative pathogens.In laboratory experiments, Opis16a inhibited all 12 bacterial strains tested. These included multidrug-resistant strains of Acinetobacter baumannii, a hospital-associated bacterium capable of causing serious bloodstream, respiratory and wound infections.Unlike conventional antibiotics that often target specific bacterial processes, Opis16a works by disrupting bacterial cell membranes. Its positively charged structure allows it to interact with negatively charged bacterial surfaces, damaging their membranes and ultimately killing the cells.

The researchers also investigated its effects in an early infection model using Galleria mellonella (wax moth) larvae. At a tested dose of 10 mg/kg, 87% of larvae treated with Opis16a survived.Why does this discovery matter?Antimicrobial resistance (AMR) is a growing global health challenge. The ability of bacteria to survive treatments that previously controlled them makes infections increasingly difficult to manage.The search for new antimicrobial compounds is therefore essential. Natural biological resources, including plants, microorganisms and animal venoms, offer valuable starting points for drug discovery.This research demonstrates how African biodiversity can contribute to molecular innovation and the development of potential antimicrobial candidates.What happens next?Despite the encouraging findings, Opis16a is still experimental. Researchers must investigate its stability in wound environments, potential toxicity, manufacturing costs and effectiveness in more advanced animal models before human clinical trials can be considered.

The discovery is a reminder that biodiversity is not only an ecological resource. It can also be a source of scientific knowledge and future medical innovation.

Original research: "Scorpion venom-derived Opis16a shows potent membrane-destabilising Gram-negative activity and promising in vivo topical efficacy" (https://doi.org/10.1038/s44259-026-00266-9).

Additional reading: "Nature Africa – Can a scorpion-venom peptide tackle drug-resistant wound infections?" (https://www.nature.com/articles/d44148-026-00345-z).MyAfroDNA | Science, genetics and African health innovation.

Africa holds extraordinary biological diversity, from its human populations to its indigenous plants, wildlife and agricultural species. Yet, the data needed to study this diversity has not always been hosted, managed or governed by institutions on the continent.

A new publication in Nature Reviews Genetics introduces the African DSI DataBank, a federated infrastructure designed to address this gap and strengthen African participation in global bioscience.

.What is digital sequence information?Digital sequence information (DSI) refers broadly to digital information derived from biological material, including DNA and RNA sequences, protein sequences and related molecular data.

Researchers use these data to study genetic variation, understand disease, improve crops, investigate biodiversity and develop new biological products.When these resources are fragmented across databases or managed outside the institutions that generated them, researchers may face barriers to access, collaboration, attribution and control.A new infrastructure for African science.

The African DSI DataBank adopts a federated model that connects institutional, national, subregional and continental data systems. Rather than requiring every institution to surrender its data to one central repository, participating institutions can maintain custody of their data while enabling discovery, collaboration and access under defined conditions.The infrastructure is designed to support different types of biological information, including genomes, proteins, environmental DNA, metagenomic data and biological imaging. It also aims to improve the visibility and attribution of African-origin data already held in international repositories.This matters because infrastructure is not simply about storing information. It determines how easily scientists can find, analyse and build upon existing knowledge.Why this matters for AfricaBetter access to genomic and biodiversity data could strengthen research into African genetic diversity, infectious diseases, crop improvement, conservation and the sustainable use of biological resources.It also raises important questions about data sovereignty, consent, benefit-sharing and research equity. African institutions need the capacity to generate and analyse biological data, alongside the infrastructure and governance systems to manage it responsibly.The DataBank represents a step towards that goal. Its long-term impact will depend on institutional participation, sustainable funding, technical capacity and effective governance.

.For African biotechnology, the opportunity is clear: build systems that allow African researchers not only to contribute biological data, but also to lead the discoveries and innovations that emerge from it.

Read the original publication: https://doi.org/10.1038/s41576-026-01017-2MyAfroDNA — Exploring African genomics, genetic diversity and the science shaping our future.

What if clues to longer, healthier lives are hidden in bat DNA?

A new study published in Nature has identified genetic patterns in long-lived Myotis bats that could help scientists better understand the relationship between longevity, immunity, DNA damage and disease resistance. Researchers analyzed the genomes of eight Myotis species and found that genes associated with longer lifespans substantially overlap with genes involved in interactions with viruses.

The research was led by Juan M. Vazquez, with Peter H. Sudmant, M. Elise Lauterbur, Lucie Etienne and David Enard among the scientists who jointly supervised the work. The international research team included scientists from the University of California, Berkeley; University of Arizona; University of Vermont; École Normale Supérieure de Lyon; Université de Strasbourg; University of Michigan and other institutions.

The researchers also examined cells obtained from bat wing biopsies. In the longest-lived species studied, the little brown bat (Myotis lucifugus), severely damaged cells showed increased activity in genes associated with cell death, rather than primarily activating DNA-repair mechanisms.

This suggests that some long-lived animals may protect themselves not only by repairing damaged cells, but also by efficiently eliminating cells that have become too damaged to safely recover. Similar cellular strategies have been observed in other long-lived, cancer-resistant animals, including elephants.

Longevity and viral defense

Another important finding was the overlap between genes associated with longevity and genes involved in interactions with viruses.

The researchers found that Myotis bats have undergone strong evolutionary selection in genes associated with DNA viruses. Their findings add to growing evidence that the evolution of immune defenses, viral interactions and mechanisms for maintaining cellular health may be closely connected.

The study does not mean that scientists have discovered a way to extend human lifespan. Instead, it provides another example of how comparative genomics can reveal biological strategies that may eventually help researchers understand human aging and disease.

For African genomics and biotechnology, the research also highlights the value of studying the genetic diversity of different species. Understanding how organisms naturally adapt to disease, environmental pressures and cellular damage can generate new questions for biomedical research.

MyAfroDNA connects research with the molecular tools that make discoveries like these possible. From DNA isolation and PCR to sequencing and molecular testing, reliable laboratory workflows are essential for studying biological samples and generating genomic data.

Interested in molecular testing or sequencing for your research project? Contact MyAfroDNA to learn more about our services.

Source: University of California, Berkeley / Nature
Research paper: Insights into longevity and virus-driven adaptation from Myotis bat genomes
DOI: 10.1038/s41586-026-10932-7

In recent years, molecular testing has become one of the most important tools in modern medicine and scientific research. From identifying infectious diseases and supporting cancer diagnosis to advancing agricultural innovation and genomic research, molecular testing is changing how we understand biology and make informed decisions.

Yet despite its growing importance, many people are still unfamiliar with what molecular testing actually involves or how it benefits healthcare, research, and industry.

At MyAfroDNA, we provide high-quality molecular testing services that support researchers, healthcare institutions, universities, biotechnology companies, and other organizations seeking accurate and reliable laboratory results. Our goal is not only to deliver dependable testing services but also to contribute to scientific advancement across Africa.

What Is Molecular Testing?

Molecular testing is a laboratory method used to detect specific genetic material—DNA or RNA—or other molecular markers within a biological sample. Unlike traditional laboratory tests that often rely on observing physical characteristics or culturing microorganisms, molecular testing examines biological material at the molecular level.

This approach allows scientists and healthcare professionals to detect diseases earlier, identify pathogens with greater precision, study genetic variations, and generate data that supports research and clinical decision-making.

Depending on the purpose of the analysis, molecular testing may involve samples such as blood, saliva, tissue, swabs, plant material, microbial cultures, environmental samples, or other biological specimens.

Why Molecular Testing Matters

The ability to detect biological changes at the molecular level has transformed healthcare and scientific research worldwide.

For healthcare providers, molecular testing can improve diagnostic accuracy and help guide treatment decisions. For researchers, it provides valuable insights into genetics, infectious diseases, biodiversity, agriculture, and environmental health.

Some of the major benefits include:

High analytical accuracy
Faster identification of pathogens and genetic markers
Improved disease surveillance
Support for precision medicine
Reliable data for scientific research
Better public health interventions

As African countries continue investing in research capacity and biotechnology infrastructure, molecular testing will play an increasingly important role in addressing local and global challenges.

Applications of Molecular Testing

Molecular testing is used across many sectors, extending well beyond hospitals and medical laboratories.

Healthcare and Clinical Diagnostics

Healthcare professionals use molecular testing to identify infectious diseases, detect inherited genetic conditions, monitor treatment responses, and support personalized medicine.

By identifying diseases at the molecular level, clinicians can make more informed decisions and provide targeted care.

Biomedical Research

Researchers rely on molecular testing to understand gene function, investigate disease mechanisms, and evaluate biological processes.

The data generated through molecular analysis contributes to publications, clinical studies, innovation, and scientific discovery.

Public Health

Public health agencies use molecular testing to monitor outbreaks, track disease transmission, identify emerging pathogens, and strengthen surveillance systems.

Rapid and accurate molecular analysis helps health authorities respond more effectively during public health emergencies.

Agriculture and Food Systems

Molecular testing supports crop improvement, livestock research, plant disease diagnosis, and food safety initiatives.

Researchers can identify pathogens affecting crops, verify species identity, and support breeding programs that improve agricultural productivity.

Environmental and Conservation Research

Scientists also use molecular techniques to study biodiversity, monitor ecosystems, identify species, and support conservation efforts.

These applications contribute to environmental protection and sustainable resource management.

Common Molecular Testing Techniques

Different laboratory methods are used depending on the objectives of the project.

Polymerase Chain Reaction (PCR)

PCR is one of the most widely used molecular techniques. It amplifies small amounts of DNA, allowing scientists to detect specific genetic sequences with high sensitivity.

PCR is commonly used in infectious disease testing, pathogen detection, genetic research, and many other laboratory applications.

Real-Time PCR (qPCR)

Real-time PCR not only detects DNA but also measures the amount of genetic material present within a sample.

This technique is valuable for quantitative analysis, gene expression studies, and clinical diagnostics.

DNA Sequencing

DNA sequencing determines the precise order of nucleotides within DNA molecules.

Sequencing enables researchers to study genetic variation, identify mutations, characterize microorganisms, and investigate biological diversity.

Genotyping

Genotyping examines specific genetic differences among individuals or populations.

It is widely used in medical research, population genetics, pharmacogenomics, and agricultural science.

The Importance of Accuracy in Molecular Testing

Reliable laboratory results depend on more than sophisticated equipment.

Accuracy begins with proper sample collection and continues through every stage of laboratory processing.

Quality molecular testing requires:

Appropriate sample handling
Standardized laboratory protocols
Validated testing methods
Quality assurance procedures
Skilled laboratory personnel
Proper interpretation of results

Each step contributes to producing dependable data that researchers and healthcare professionals can trust.

Supporting Scientific Research Across Africa

Africa possesses the world's greatest human genetic diversity, making the continent uniquely important for genomic research.

However, African researchers have historically faced limited access to advanced molecular laboratory services.

Expanding local molecular testing capacity helps strengthen research institutions, improve public health, support innovation, and reduce dependence on overseas laboratories.

By investing in molecular science within Africa, researchers can generate locally relevant data while building sustainable scientific infrastructure.

Molecular Testing at MyAfroDNA

At MyAfroDNA, we support organizations and researchers through a range of molecular laboratory services designed to meet international scientific standards.

Our laboratory works with researchers, universities, healthcare institutions, biotechnology organizations, conservation projects, and industry partners requiring dependable molecular analysis.

Our services support applications such as:

Molecular biology research
Pathogen identification
DNA extraction
PCR-based analysis
DNA sequencing
Species identification
Genetic research
Biospecimen processing
Laboratory consultation

Every project is approached with scientific rigor, attention to quality, and respect for client confidentiality.

Selecting a molecular laboratory is an important decision.

Choosing the Right Molecular Testing Partner

When evaluating a laboratory, consider the following:

Scientific expertise: Does the laboratory have experienced molecular scientists?

Quality systems: Are standardized laboratory procedures and quality assurance measures in place?

Technology: Does the laboratory use modern molecular techniques appropriate for your project?

Communication: Will you receive clear guidance before, during, and after testing?

Project support: Can the laboratory provide technical expertise for both routine and specialized analyses?

Working with an experienced laboratory helps ensure reliable results while supporting successful research outcomes.

The Future of Molecular Testing in Africa

The demand for molecular testing continues to grow across healthcare, agriculture, environmental science, and biotechnology.

Advances in genomics, artificial intelligence, precision medicine, and molecular diagnostics will create new opportunities for researchers, healthcare professionals, and policymakers.

As investment in African science continues to increase, local laboratories will play an increasingly important role in generating high-quality data that addresses regional priorities and contributes to global knowledge.

At MyAfroDNA, we are committed to being part of that future by supporting scientific excellence, expanding access to molecular laboratory services, and contributing to research that improves lives across Africa.

Looking Ahead

Molecular testing has become an essential component of modern science. Its applications span healthcare, research, agriculture, conservation, and public health, providing insights that were once impossible to obtain.

Whether advancing biomedical discovery, supporting disease surveillance, or enabling innovative research, molecular testing continues to shape the future of science.

At MyAfroDNA, we are proud to support this progress through reliable molecular laboratory services, scientific expertise, and a commitment to quality.

If your institution, research team, or organization requires molecular testing services or would like to discuss a research project, our team is ready to help you identify the most appropriate laboratory solutions for your needs.